可能与 mRNA COVID-19 疫苗有关的眼震-肌阵挛-共济失调综合征。
Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
机构信息
Kocaeli University Faculty of Medicine, Department of Pediatrics, Division of Child Neurology, Kocaeli, Turkey.
Kocaeli University Faculty of Medicine, Department of Pediatrics, Division of Child Neurology, Kocaeli, Turkey.
出版信息
J AAPOS. 2023 Apr;27(2):110-112. doi: 10.1016/j.jaapos.2022.12.001. Epub 2023 Jan 31.
Opsoclonus-myoclonus-ataxia syndrome (OMAS) in children is most often of paraneoplastic origin, but it can also result from infectious processes, toxic and metabolic disorders, and organic events that cause damage to the brainstem or cerebellum. Post-vaccination OMAS has also been reported. We report the case of a 15-year-old girl who developed OMAS 24 hours after her first dose of mRNA COVID-19 (BioNTech) vaccine.
儿童发作性眼球运动性小脑共济失调（OMAS）多为副肿瘤性疾病，但也可由感染过程、中毒和代谢紊乱、以及导致脑干或小脑损伤的器质性事件引起。接种疫苗后也有 OMAS 的报道。我们报告了一例 15 岁女孩在接种第一剂 mRNA COVID-19（BioNTech）疫苗后 24 小时出现 OMAS 的病例。
Zotero 插件